Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher J. Lindop currently holds 376,647 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Lindop has been a net seller of HAE stock. They have purchased $188.2K and sold $13.8M worth of shares.
Christopher J. Lindop's most recent insider trade was on May 24, 2020, when they sold 25,271 shares at $0.00 per share.
Christopher J. Lindop serves as Executive at HAEMONETICS CORP (HAE). They have executed 127 insider transactions totaling $14.0M over their tenure at the company.
Christopher J. Lindop holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Christopher J. Lindop has shown a selling trading pattern, with $188.2K in total purchases and $13.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher J. Lindop was on Jun 18, 2013, when they sold $2.9M worth of HAE shares. This transaction involved 68,628 shares at $42.50 per share.
Christopher J. Lindop currently owns 376,647 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher J. Lindop's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher J. Lindop has 127 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Christopher J. Lindop and 40,000+ other insiders.